Intrarosa (prasterone) vaginal insert
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Intrarosa (prasterone) vaginal insert, covering 2017-11-28 to 2024-09-23. Get the full timeline:
Most recent: Clinical Trial Update: Vaginal Dehydroepiandrosterone (DHEA) in Postmenopausal Breast Cancer Survivors on Aromatase Inhibitors [Phase 2]